scientific advisory board

 

Tommy B. Andersson, AstraZeneca, Mölndal, Sweden

Joachim Blanz, Novartis Institutes for Biomedical Research, Basel, Switzerland

Ann Daly, Newcastle University, Newcastle upon Tyne, UK

Vita Dolzan, University of Ljubljana, Ljubljana, Slovenia

Andrea Gaedigk, Children's Mercy Kansas City, Kansas City, MO, USA

Elizabeth Gillam, University of Queensland, Brisbane, Australia

Magnus Ingelman-Sundberg, Karolinska Institutet, Stockholm, Sweden

Urs Meyer, Biozentrum, University of Basel, Basel, Switzerland

John Miners, Flinders University, Adelaide, Australia

Ryan Morgan, Amgen, Los Angeles, CA, USA

Maciaj Zamek-Gliszczynski, Lilly Research Laboratories, Indianapolis, IN, USA